A paradox of Flt-1, a tyrosine kinase receptor for vascular endothelial growth factor (VEGF), is that the ligand cannot activate the receptor to stimulate growth of cells that exogenously overexpress the receptor. In order to ®nd Flt-1 kinase-dependent biological systems, we obtained for the ®rst time activated forms of the Flt-1 kinase in a ligand-independent manner. Replacement of the ABL sequences in the human leukemia oncoprotein BCR ± ABL with the cytoplasmic domain of Flt-1 (BCR ± FLT) followed by a retroviral random mutagenesis scheme gave constitutively active arti®cial chimera BCR ± FLTm with mutations within the Flt-1 sequence. Like BCR ± ABL it could, but not the original BCR ± FLT, transform Rat1 ®broblasts, abrogate cytokine dependence in Ba/F3 cells, and induce neurite-like structures in neuronal PC12 cells. Interestingly, Rat1 cells transformed by BCR ± FLTm formed tube-like structures in basement membrane matrix. BCR ± FLTm retroviruses may be a very useful tool to investigate an as yet uncovered functions of the Flt-1 kinase.
Introduction
Angiogenesis is involved in many physiological as well as pathological circumstances including wound healing, organ regeneration, cyclic proliferation of uterine endometrium, metastasis or neovascularization of cancer, retinopathy in diabetes mellitus and so forth (reviewed in Folkman and Shing, 1992) . One of the directly-acting mitogens involved in this process is vascular endothelial growth factor (VEGF) (Ferrara and Davis-Smyth, 1997) . Two separate VEGF receptors of platelet derived growth factor receptor (PDGFR) family have been identi®ed; Flt-1 De Vries et al., 1992; Shibuya, 1995) and KDR/Flk-1 (Terman et al., 1992; Millauer et al., 1993) . Recent studies on mice de®cient in either of these receptors suggested that Flt-1 may regulate the assembly of endothelial cells (Fong et al., 1995) and KDR/Flk-1 plays an important role in vasculogenesis and blood island formations (Shalaby et al., 1995) . KDR/Flk-1 expressed in non-endothelial cells has been reported to stimulate DNA synthesis in response to VEGF (Millauer et al., 1993) . However, Flt-1 does not mediate cell growth when introduced into NIH3T3 cells or into porcine aortic endothelial cells that express no VEGF receptors Waltenberger et al., 1994) . The Flt-1-mediated biological activities of VEGF elucidated so far include tissue factor production in endothelial cells (Clauss et al., 1996) , nitric oxide release in trophoblast cells (Ahmed et al., 1997) and migration of monocytic cells (Barleon et al., 1996) . More recently Ziche et al. have claimed that the Flt-1-speci®c ligand placenta growth factor (PlGF)-1, when puri®ed from overexpressing eukaryotic cells, was as potent as VEGF to induce angiogenesis in the rabbit cornea and the chick chorioallantoic membrane assays (Ziche et al., 1997) . These informations raise a fundamental question of whether the Flt-1 tyrosine kinase activity can promote cell growth or it has other biological functions.
In order to address to this issue, we attempted to obtain activated forms of the Flt-1 kinase in a ligandindependent fashion. The initial step for activation of receptor tyrosine kinases requires dimerization or oligomerization of receptors by ligand binding (Ullrich and Schlessinger, 1990; Heldin, 1995) . The recent discovery of the chimeric transforming oncoprotein Tel ± PDGFR suggests that the tyrosine kinase domain of the PDGFR family members could be constitutively activated by the fusion of helix ± loop ± helix domain of an ets-related transcription factor Tel with a dimerizing potential (Golub et al., 1994) . The tetramer domain of the amino-terminal BCR fragment with an alpha helical coiled-coil structure is essential for all biological activities for another transforming tyrosine kinase BCR ± ABL (McWhirter et al., 1993a; Maru et al., 1996a) . We replaced the ABL tyrosine kinase domain of P185 BCR ± ABL with that of Flt-1 and expected the activation of the Flt-1 kinase. Surprisingly, the resulting arti®cial chimera BCR ± FLT had no biological activity as judged by Rat1 cell transformation or growth factor independence in both of which BCR ± ABL is active. Then we made our eorts to obtain oncogenically mutated forms of the BCR ± FLT by taking advantage of the highly mutagenic nature of retrovirus life cycle (Goga et al., 1993) . Because retrovirally transduced oncogenic forms of c-kit or EGF receptor, v-kit or v-erbB, respectively, have multiple mutations in addition to the amino-terminal truncation (Nilsen et al., 1985; Qiu et al., 1988) . Here we report the establishment of retroviruses expressing activated forms of BCR ± FLT and show their transforming as well as morphogenic potentials.
Results

BCR ± TRK is active in vivo while BCR ± FLT is not
The ABL kinase domain and downstream sequences in BCR ± ABL were replaced with the intracellular portion of Flt-1 (Figure 1a) . For an experimental control we also used the receptor for nerve growth factor Trk because its biological activities based on molecular analysis have been well studied (MartinZanca et al., 1989; Coulier et al., 1990; Obermeier et al., 1994; Stephens et al., 1994) . We avoided simple fusions of the BCR sequences with oligomerizing ability to the kinase domain of the receptors. Because BCR ± ABL with a deletion in the SH2 domain has changes in its activity (Afar et al., 1994) and therefore can no longer serve as a control. The resulting arti®cial chimeras were named as BCR ± FLT and BCR ± TRK, respectively. When they were expressed in the transient 293T transfection system, BCR ± TRK was shown to be tyrosine-phosphorylated (Figure 1b , lane 8) at a high level comparable to that in BCR ± ABL. This suggests that other kinases of receptor type can potentially be activated by fusion to BCR in the presence of the ABL SH3/SH2 domains. Surprisingly, however, anti-phosphotyrosine (PY) Western blotting showed complete absence of PY-containing proteins in cells transfected with BCR ± FLT (Figure 1b, lane 7) . In order to examine whether or not BCR ± FLT can function as an enzyme in vitro, immunopuri®ed chimeric proteins were subjected to in vitro kinase assays followed by anti-PY Western blotting. As shown in Figure 1b (lanes 9 ± 12), autophosphorylation of BCR ± FLT was detected, indicating that the Flt-1 kinase retains enzymatic activity even in the context of BCR ± FLT but that the activity may be downregulated in vivo.
Establishment of retroviruses expressing activated forms of BCR ± FLT
The facts that the Flt-1 kinase can hardly be activated in the context of BCR ± FLT in vivo but that it still retains the kinase activity in vitro may partly re¯ect extremely weak autophosphorylations or activation of Flt-1 extrinsically expressed in NIH3T3 cells . They also suggest that the BCR tetramer domain-mediated oligomerization alone may not be sucient for activation of the Flt-1 tyrosine kinase. Considering VEGF-induced tyrosine phosphorylations of PLCg and GAP (GTPase-activating protein) for Ras in Flt-1-expressing NIH3T3cells, the Flt-1 kinase activity, although weak, can potentially transmit signals but the activity may not be high enough to exert biological eects in the usual tissue culture system Shibuya, 1995) . Therefore we challenged to obtain activated forms of BCR ± FLT by utilizing the retroviral random mutagenesis scheme described before (Goga et al., 1993) .
Retroviruses have a highly mutagenic property in natural conditions and many of the well-known oncogenes virally transduced from host cells contain gain-of-function mutations (Nilsen et al., 1985; Qiu et al., 1988) . Rat1 cells infected with helper-free retroviruses expressing BCR ± FLT fused either in-frame or purposely out-of-frame were plated into soft agar, and we expected that Rat1 cells infected with oncogenically mutated BCR ± FLT retroviruses could give rise to an anchorage-independent growth. In three independent soft agar assays performed in this fashion, four colonies (clone 1 ± 4) were observed in BCR ± FLT with an in-frame fusion while BCR ± FLT with an outof-frame fusion always gave no colonies and BCR ± ABL uncountable number of colonies. Cells derived from each of the four colonies plated back into liquid culture revealed transformed morphology (data not shown). They also formed colonies when replated into soft agar. Integrated retroviruses with BCR ± FLT cDNAs that were expected to contain activated mutations were rescued from those transformed clones by infection with replication-competent Molony Figure 1 (a) Schematic representation of BCR ± TRK and BCR ± FLT. Intracellular domains of nerve growth factor receptor (NGF-R or TRK) and vascular endothelial growth factor receptor (VEGF-R or FLT-1) were substituted for the ABL sequences in BCR ± ABL. Y490 and Y785 in TRK indicate tyrosine residues responsible for binding to Shc and PLCg, respectively. Arrows show the junctions between the ABL SH2 domain and the fused receptor sequences. TM=transmembrane domain. (b) BCR ± TRK is activated while BCR ± FLT is not. Total protein lysates (lanes 1 ± 8) or anti-BCR immunoprecipitates after in vitro kinase reactions (lanes 9 ± 12) from 293T cells transfected with vector alone (MOCK) (lanes 1, 5, 9), P185 BCR ± ABL (lanes 2, 6, 10), BCR ± FLT (lanes 3, 7, 11), and BCR ± TRK (lanes 4, 8, 12) were subjected to anti-BCR (lanes 1 ± 4) or anti-phosphotyrosine (lanes 5 ± 12) Western blotting Murine Leukemia Virus. Reinfection of Rat1 cells with the rescued viruses gave G418-resistant transformed foci that formed colonies in soft agar (data not shown).
To con®rm the expression of the BCR ± FLT proteins in Rat1 clone 1 ± 4, anti-BCR Western blotting was performed (Figure 2a ). The expression levels of BCR ± FLT in non-transformed cells that express the original BCR ± FLT and in transformed clones were roughly equal, and were also similar to those in BCR ± ABL-transformed cells (Figure 2a) . The protein size of BCR ± FLT in clone 2 is approximately 20 KD smaller than that of other clones (Figure 2a , lane 4). Anti-PY Western blotting revealed that autophosphorylation intensities of activated BCR ± FLTs and BCR ± ABL were approximately the same (Figure 2b) . Interestingly, tyrosine phosphorylation of GAP-associated p62Dok (Carpino et al., 1997; Yamanashi and Baltimore, 1997) , which is a good indicator for the BCR ± ABL-mediated transformation, was totally absent in the activated forms of BCR ± FLT. In addition to autophosphorylation bands of BCR ± FLT, a protein of around 150 KD (pp150) was strongly tyrosine-phosphorylated in every clone. This protein is not BCR ± FLT itself that is posttranslationally modi®ed, because it could not be detected by anti-BCR Western blotting ( Figure 2a ) and because an exactly same-sized phosphoprotein was also observed in clone 2 that expresses a short-sized BCR ± FLT (Figure 2b) .
Southern blot analysis of the Rat1 clones has revealed that BCR ± FLT was integrated into the rat genome with a single copy (Figure 2d ). Considering the sizes of bands in EcoRI-digested DNAs, clones 1, 3 and 4 are possibly identical. Polymerase chain reaction (PCR) analysis of DNAs and reverse transcriptasemediated PCR (RT ± PCR) of RNAs of those Rat1 clones showed that the Flt-1 sequence has a point mutation at nucleotide 2743 (T to A) (amino acid 832 Ser to Thr) in clones 1, 3 and 4 and that clone 2 has mutations at nucleotide 3103 (G to T) (amino acid 952 Gly to Cys) and at nucleotide 3835 (G to T) (amino acid 1196 Glu to stop). These data strongly support the , or from transformed colonies (lanes 1 to 4, 8 to 11 for C1 to C4, respectively), 10 pg (lanes 6, 13) or 100 pg (lanes 7, 14) of BCR ± FLT DNAs in the retroviral expression vector were digested by either EcoRI (lanes 1 to 7) or XbaI (lanes 8 to 14), and were subjected to Southern blot analysis using 3' Flt-1 (SacI/XbaI) probe interpretation of the data in Southern blot analysis and explain the smaller protein size in clone 2. However, BCR and ABL sequences containing the SH2 and SH3 domains had no mutations. Thus we have established two retroviruses that express BCR ± FLT with oncogenic mutations. Since the carboxy-terminal truncation in the activated form of BCR ± FLT derived from clone 2 may result in loss of functions that belong to this region, we did most of the following experiments with the activated form derived from clone 1 that contains the full-length BCR ± FLT and named it BCR ± FLTm.
BCR ± TRK and BCR ± FLTm have transforming abilities
It is known that Trk was initially identi®ed as a chimeric oncoprotein with tropomyosin that can transform NIH3T3 cells (Martin-Zanca et al., 1986) . The recombination constitutively activates the Trk tyrosine kinase. Given the fact that BCR ± TRK expressed in the transient 293T transfection system was biochemically activated (Figure 1 ), both BCR ± TRK and BCR ± FLTm were expected to have transforming potentials. When retrovirally expressed in Rat1 ®broblasts, they induced not only morphological changes (Figure 3b ) but also anchorage-independent growth in soft agar. Judging from the number of macroscopic colonies in soft agar assays performed with roughly equivalent titers of retroviruses, both of them were as transforming as v-ABL (Figure 3a) . Although morphologies of transformed Rat1 cells by each retrovirus were indistinguishable, a unique morphology were observed in cells transformed by BCR ± FLTm when cells were starved of serum for 24 ± 48 h. They showed an anastomosing reticular pattern that is morphologically similar to capillary-like networks formed by endothelial cells (Folkman and Haudenschild, 1980; Montesano et al., 1983) (Figure 3b, 4) , while cells transformed by other retroviruses appeared apoptotic without any changes in cell alignment.
Tyrosine phosphorylation and recruitment of proteins in cells that express BCR ± TRK and BCR ± FLTm
Anti-BCR Western blotting of the transformed Rat1 ®broblasts showed that BCR ± ABL, BCR ± FLTm and BCR ± TRK were autophosphorylated (Figure 4 , lanes 1 ± 10). The absence of tyrosine phosphorylations of GAP-associated p62Dok was not only reproduced in cells reinfected with the BCR ± FLTm retrovirus but also was observed in BCR ± TRK-transformed cells (Figure 4 , lanes 8 and 9). Tyrosine phosphorylations of p62Dok were reported in many tyrosine kinases including v-ABL, v-FPS, v-SRC, epidermal growth factor receptor (EGF-R), PDGF-R and Flt-1 but not in Trk (Carpino et al., 1997; Ellis et al., 1990; Maher, 1988; Seetharam et al., 1994) . However, anti-PY Western blotting of anti-GAP immunoprecipitates from BCR ± FLTm or BCR ± TRK-expressing cells also revealed that tyrosine phosphorylation of p62Dok was hardly detectable (Figure 4 , lanes 13 and 14). Presently we have no explanation for the dierence in p62Dok phosphorylation between Flt-1-expressing NIH3T3 cells and BCR ± FLTm-expressing Rat1 cells. Interestingly, another GAP-associated protein p190 (Settleman et al., 1992) was tyrosine phosphorylated in all of the transformed cells. Tyrosine phosphorylation of GAP appeared to correlate with that of p190 (Ellis et al., 1990) but it was under detection in BCR ± FLTm-transformed cells.
We then examined tyrosine phosphorylation of potential substrates or recruitment of proteins in BCR ± FLTm-transformed cells. We focused on three signal transduction molecules of biological importance: GRB-2, Shc, and PLCg. The tyrosine residue 177 (Y177) of BCR ± ABL is phosphorylated in BCR ± ABL and it transduces a Ras-mediated signal through recruitment with an SH2/SH3-containing adapter molecule GRB-2 that is complexed to SOS, a GDP/ GTP exchanger for Ras . Shc is highly tyrosine-phosphorylated in BCR ± ABL-transformed cells and makes an alternative Ras pathway (Puil et al., 1994; Goga et al., 1995; Maru et al., 1996a) . Previously we have shown that PLCg could be tyrosine-phosphorylated with VEGF stimulation in NIH3T3 cells that overexpress Flt-1 . In Trk it is known that Shc and PLCg associate with the autophosphorylated receptor at Y490 and Y785, respectively (Obermeier et al., 1994; Stephens et al., 1994) . Both tyrosine residues are demonstrated to be essential for neuronal differentiation of PC12 cells. Since they are retained in BCR ± TRK (Figure 1a) , we expected that it may serve as a good control to monitor the protein interactions discussed above. Shc was tyrosine-phosphorylated in all of the transformed cells (Figure 5a ). Recruitment of autophosphorylated BCR ± TRK with Shc was evident as expected ( Figure 5a and b, lane 4) . Although BCR ± FLTm bound to Shc was not detectable in anti-BCR Western blotting, anti-PY Western blotting revealed a faint band of BCR ± FLTm (Figure 5a and b, lane 3) . Although both BCR ± ABL and v-ABL have been shown to bind to Shc (Puil et al., 1994; Rael et al., 1996) , it was undetectable in this stringent condition.
Anti-GRB-2 Western blotting of anti-Flt-1 and antiTrk immunoprecipitates revealed the binding of GRB-2 to BCR ± FLTm as well as to BCR ± TRK (Figure 5c ). The binding of GRB-2 in BCR ± ABL is predominantly mediated by Y177 in the BCR sequence (Pendergast et al., 1993; Afar et al., 1994) . In addition to Y177, BCR ± TRK also eciently recruits Shc which can bind to GRB-2. There is a potential GRB-2 binding site in the carboxy-terminal Flt-1 sequence (1213 YVNA) which is conserved in human, mouse, and rat (Shibuya, 1995) . This site may be involved in but certainly is not required for GRB-2 binding in BCR ± FLTm because the activated BCR ± FLT derived from clone 2, which has a stop codon at 1196, was also recruited with GRB-2 (data not shown).
PLCg was also tyrosine-phosphorylated in every transformant but its recruitment was observed only in BCR ± FLTm and BCR ± TRK (Figure 6a) . The reported molecular size of PLCg is 145 KD but we do not suppose that pp150 that appeared in Figure 2b is PLCg by two reasons. One is the dierence in the apparent molecular size. PY-containing PLCg which comigrates with BCR ± FLTm was detected also in cells transformed by activated BCR ± FLT derived from clone 2 (Figure 6b, lanes 1 ± 3) . Another reason is that anti-Flt-1 immunoprecipitates from cells expressing BCR ± FLTm (from clone 1) contained both BCR ± FLTm and pp150 while those from clone 2 showed the truncated form of BCR ± FLT but not pp150, although in both cases roughly equivalent amounts of PLCg were recruited with the activated forms of BCR ± FLT (Figure 6b , lanes 4 ± 6). These data suggest that pp150 is complexed to BCR ± FLTm through the carboxy-terminal Flt-1 sequences 1197 ± 1338, and that PLCg is recruited with BCR ± FLTm through other sequences.
Biological activities of BCR ± FLTm and BCR ± TRK distinct from those of BCR ± ABL
In addition to the transformation assay of Rat1 ®broblasts (Lugo and Witte, 1989) , the biological activities of BCR ± ABL can be tested in several convenient assays, which include abrogation of growth factor dependence in interleukin-3 (IL-3)-dependent cell line Ba/F3 (Daley and , transformation of mouse bone marrow cells (McLaughlin et al., 1987) , and partial induction of neurite extension in neuronal PC12 cells (Maru et al., 1996b) . Although both BCR ± FLTm and BCR ± TRK abolished IL-3 dependence in Ba/F3 cells, neither of them could transform mouse bone marrow cells in primary culture (Table 1 ). In the absence of NGF, both BCR ± FLTm and BCR ± TRK induced neurite-like structures that were morphologically similar to those previously reported in BCR ± ABL (Figure 7b,c,d ). BCR ± TRKtransformed PC12 cells showed long neurites with less prominent branching in the absence of NGF but the induced morphology was certainly dierent from that in terminally dierentiated PC12 cells by NGF addition (Figure 7c,f) . Although activation of MAP kinase kinase has been shown to be necessary and sucient for PC12 dierentiation (Cowley et al., 1994) and constitutive activation of MAP kinases has been reported in v-ABL-expressing cells (Raitano et al., 1995) , PC12 cells transformed by v-ABL were round or spindle-shaped and showed extensions of short processes (Figure 7e ). Since Rat1 cells transformed by BCR ± FLTm showed capillary-like networks on usual tissue culture dishes when starved of serum, we plated the cells onto basement membrane matrix (Matrigel) which is often utilized to study lumen formations by endothelial cells (Folkman and Haudenschild, 1980; Montesano et al., 1983) . Interestingly they formed cell aggregates of 100 ± 200 mm in diameter with radiating cords that were observed neither in the control Rat1 cells (Figure 8a, b) nor in other Rat1 cell transformants shown in Figure 3 (data not shown). Histological sections revealed that Rat1 cells, whether transformed or not, invaded into Matrigel. Typical apoptoic features like nuclear fragmentation and vacuolar degeneration were observed in the center of aggregations of BCR ± FLTmtransformed cells (Figure 8c ). In contrast both surrounding cells that attached to Matrigel and cord-forming cells were alive, and showed structural continuity. Sections of cords revealed that a few cells participated in the formations of lumen-like structures with neither Matrigel nor cell debri in the inner space (Figure 8d ). Although Rat1 ®broblasts were originally derived from embryo (Freeman et al., 1973) , we assume that they have a potential to form lumen-like structures like those in endothelial cells. The ability of Ba/F3 cells to be rendered IL-3-independent for growth following infection by BCR±FLTm and BCR±TRK retroviruses. Wells were scored positive when they showed outgrowth of IL-3 independent cells after 4 weeks. Bone marrow cells in primary culture from BALB/c mice were infected with the retroviruses. Cultures were scored positive when lymphoid outgrowth was observed after 4 weeks. The number of cultures positive over total is shown. The retroviral titers were normalized to give roughly equivalent expression following infection to Rat1 ®broblasts (see Functions of full length Flt-1 with or without mutation overexpressed in NIH3T3 cells
We have previously reported that full length Flt-1 overexpressed in NIH3T3 cells (Flt-1/NIH3T3) could transmit biochemical signals upon VEGF stimulation but not exert growth stimulatory eects . In order to examine whether or not the gainof-function mutation that BCR ± FLTm acquired could in¯uence functions of the original Flt-1, Flt-1 with the mutation was reconstructed (Flt-1m) and was expressed in NIH3T3 cells (Flt-1m/NIH3T3) at a level comparable to that of Flt-1/NIH3T3 reported previously (Figure 9a, upper  panel) . VEGF-induced autophosphorylation activities were 10 ± 20% higher in Flt-1m than in Flt-1 ( Figure  9a, lower panel) . Then we expected VEGF-dependent colony formation in soft agar in Flt-1m/NIH3T3 cells. Surprisingly, however, NIH3T3 cells that overexpressed the original Flt-1 showed anchorage-independent growth in soft agar even in the absence of VEGF and addition of VEGF in soft agar had almost no eect on the number of colonies (Figure 9b ). Flt-1m/ NIH3T3 cells gave approximately 20% higher colony numbers than Flt-1/NIH3T3 cells but again VEGF could not further increase the number of colonies. Since transformed tumor cells have been reported to frequently produce VEGF, we ®rst thought about activation of Flt-1 by autocrine mechanism. However, when we treated those cells with a blocking antibody against murine VEGF, it could not in¯uence their growth (data not shown). Although we do not know the precise molecular mechanism, we assume that overexpression by itself could also confer transforming potentials upon Flt-1. Because expression levels of Flt-1 correlated with transformed morphologies (data not shown) and because NIH3T3 cells that expressed vector alone did not show transformed phenotypes (Figure 9b ). Although colony formation by Flt-1-expressing cells was VEGF-independent, we observed VEGF-dependent biological phenotypes when they were plated onto Matrigel. In the absence of VEGF, NIH3T3 cells that overexpressed wild type Flt-1 formed a cyst-like structure (Figure 9c, panel 2) . It appeared to be morphologically similar to what we observed in Rat1 ®broblasts transformed by BCR ± FLTm (see Figure 8 for comparison) . However, the central space contained Matrigel and a small number of cells that were not apoptotic (Figure 9c, panel 4) . Addition of VEGF appeared to abolish the continuity of surrounding cell layers and to promote cellular contact with adjacent cyst-like structures ( Figure 9c , panel 2). Histological sections revealed that cyst-like structures were no longer observed in the presence of VEGF and cells appeared to migrate in every direction. No signi®cant dierences were observed in this morphogenic activity between NIH3T3 cells overexpressing Flt-1 and Flt-1m. 
Discussion
We have shown here that the cytoplasmic portion of Trk containing the tyrosine kinase domain can be activated by fusion to the cassette of the BCR ®rst exon/the ABL SH3 and SH2 domains (BCR ± TRK), while that of Flt-1 cannot (BCR ± FLT). The Trk oncogene was initially identi®ed in a human colon cancer as a fused oncogene with truncated tropomysin (Martin-Zanca et al., 1986) . Although the Trk can be activated in experimental systems by point mutation, in-frame deletion, and duplication of the kinase domain, the tropomysin sequences are presumed to induce dimerization (Coulier et al., 1990) . Recently it was shown that the oligomerizing property of the transcription factor Tel activates both PDGFR and ABL in human leukemias with speci®c chromosome translocations (Golub et al., 1994 (Golub et al., , 1996 . The oligomerizing property of BCR ®rst exon-encoded sequence can function in a similar fashion. The subsequent random mutagenesis scheme utilizing the highly mutagenic property of retroviruses has enabled us to obtain activated forms of BCR ± FLT. Although this is the ®rst time that the Flt-1 kinase was activated to exert transforming abilities, activation mechanism in BCR ± FLTm still remains to be elucidated. The Ser to Thr mutation found in BCR ± FLTm is adjacent to the ATP binding GXGXXG motif . PDGFR, Fms and c-Kit have threonine at this position, whereas none of the Flt family members, Flt-1, KDR/Flk-1, and Flt-4 (Pajusola et al., 1992) has threonine at this position. Retrovirally transduced oncogenic forms of c-Kit or EGFR, v-Kit or v-ErbB, respectively, have multiple mutations in addition to the amino-terminal truncation (Nilsen et al., 1985; Qiu et al., 1988) . The Gly to Cys mutation in the kinase insert region derived from clone 2 may induce dimerization of the kinase domain by a disul®de bond. The kinase domains of EGFR and p185 c-neu can associate as dimers to create an ecient signaling assembly and to result in oncogenic cellular transformation (Murali et al., 1996) . Homodimerization and constitutive activation are also observed in the erythropoietin receptor with exoplasmic domain mutation converting Arg to Cys (Watowich et al., 1992) .
We have found no signi®cant dierences among BCR ± ABL, BCR ± FLTm and BCR ± TRK in tyrosine phosphorylation of Shc, PLCg and p190, and in recruitment of the Ras-signaling adaptor molecule GRB-2. However, Rat1 cells transformed by BCR ± TRK or BCR ± FLTm did not contain tyrosinephosphorylated p62Dok that were coimmunoprecipitable with Ras-GAP. We have previously reported VEGF-induced tyrosine phosphorylation of p62Dok in Flt-1-expressing NIH3T3 cells . Since p62Dok is highly phosphorylated in BCR ± ABL, the fusion with BCR sequences by itself may not be responsible for the loss of its phosphorylation. We assume that subcellular localization might explain the dierence. The carboxy-terminal tail of ABL is involved in actin cytoskeleton-binding (McWhirter and Wang, 1993b; van Etten et al., 1994) . But immunostaining of BCR ± FLT or BCR ± TRK in the 293T overexpression system revealed that they are not associated with actin micro®laments (data not shown). However, p190 appeared to be tyrosine-phosphorylated in cells expressing any one of those three kinases. Biological signi®cance of the dissociation in tyrosine phosphorylation between p62Dok and p190 needs to be investigated. Both of them are phosphorylated in v-ABL-transformed cells (Ellis et al., 1990) . v-ABL mutants with carboxy-terminal truncations are compromised in the ability to transform lymphoid cells but not NIH3T3 ®broblasts. This correlates well with low levels of tyrosine phosphorylation in p62Dok . Although BCR ± TRK and BCR ± FLTm could transform Rat1 ®broblasts as eciently as v-ABL, they could not transform lymphoid cells of mouse bone marrow. Consistent with the previous report on the inability of v-ABL/Src chimera to transform lymphoid cells (Mathey-Prevot and Baltimore, 1988) , activated receptor kinases Trk and Flt-1 could not substitute for ABL in the context of BCR ± ABL to transform lymphoid cells.
Autophosphorylated BCR ± FLTm and pp150 are the two major phosphotyrosine-containing proteins in BCR ± FLTm-transformed cells (Figure 2b ). We assume that one candidate for pp150 is an inositol tetraphosphate and phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP) which is induced to associate with Shc by multiple cytokines (Damen et al., 1996) . Anti-PY Western blotting of anti-Shc immunoprecipitates from the transformed Rat1 cells showed that a tyrosine-phosphorylated protein around 150 KD associated with Shc ( Figure 5 ). IL-3 dependence in Ba/F3 cells is abrogated by BCR ± FLTm (Table 1 ) and pp150 can also be detected in IL-3-independent cells that express BCR ± FLTm (data not shown). Although recruitment of SHIP to Shc is induced by cytokines, the SHIP transcripts have been shown to be detected not only in bone marrow but also in many other non-hematopoietic tissues (Damen et al., 1996) .
While BCR ± ABL has a hematopoietic cell specificity for transformation, both BCR ± FLTm and BCR ± TRK appear to have unique biological features that may be related to the biology of the original receptor forms. Compared with partial neurite extensions by BCR ± ABL and BCR ± FLTm in the PC12 system, BCR ± TRK caused rather long extensions of neurites in the absence of NGF. Rat1 cells transformed by BCR ± FLTm not only formed capillary-like network structures in the usual liquid culture system when deprived of serum but also displayed 3-dimensional lumen-like structures in basement membrane matrix. This implies the presence of kinase-speci®c substrates that are responsible for those biological phenotypes. Expression of the receptor Flt-1 is restricted to endothelial cells and macrophages (Shibuya, 1995; Barleon et al., 1996) . VEGF has been shown to promote the formation of capillary-like networks in endothelial cells (Ferrara and Davis-Smyth, 1997) . Our data that VEGF-activated Flt-1 could transmit neither morphogenic nor growth stimulatory signal in the usual tissue culture system or in soft agar but could induce cell realignment in Matrigel suggest that Flt-1 might cooperate with signals from extracellular matrix. However, there has been no reports on the Flt-1-mediated VEGF activity for the morphogenic behavior of endothelial cells. This may be due to experimental diculties in endothelial cells. For example, endothelial cells, whether in primary culture or established as cell lines, are usually destined to form lumens in extracellular matrix. It may be useful if there are endothelial cells that lack the ability to form lumens. Overexpression of receptor form of Flt-1 or BCR ± FLTm in such cells might enable us to test if the activated forms of Flt-1 kinase is in fact responsible for the endothelial morphogenesis.
Materials and methods
Cells
Rat1 cells and 293T cells were cultured in Dulbecco's modi®ed Eagle medium (DMEM) with a 10% fetal calf serum (FCS). PC12 cells were maintained with DMEM/ 10% FCS/5% horse serum. Ba/F3 cells were cultured in RPMI/10% FCS supplemented with 10% conditioned medium from actively growing WEHI-3B cells as a source of interleukin-3 (IL-3). Transformation assays of Rat1 cells (Lugo and Witte, 1989) , PC12 cells (Maru et al., 1996b) , mouse bone marrow cells (McLaughlin et al., 1987) , and Ba/F3 cells (Daley and Baltimore, 1988) and transfection of 293T cells were performed as described previously . NIH3T3 cells overexpressing Flt-1 and their culture conditions were reported previously . Matrigel was purchased from Beckton Dickinson and 300 ml was used in 24-wells culture plates. Approximately 10 3 to 10 4 cells were plated onto Matrigel. VEGF at 100 ng/ml was added to cell layers in soft agar colony assay or Matrigel cultures.
Molecular construction
Construction of BCR ± FLT was performed as follows. P¯MI site (2705) of Flt-1 was blunted by Klenow and either 8 bp (GGAATTCC) or 10 bp (CCGAATTCGG) EcoRI linkers were added. The 5' BCR ± ABL XbaI/KpnI fragment from pGEM4/p185 BCR ± ABL and the KpnI/EcoRI fragment from pGEX3X-(1021 ± 1120)P210[SH2] were ligated. This XbaI/EcoRI fragment was fused with the EcoRI/XbaI fragment containing the Flt-1 kinase domain. The fusion is in-frame when 8 bp EcoRI linkers were used but out-of-frame with 10 bp linkers. Construction of BCR ± TRK was started with pLM6 kindly provided by Dr M Barbacid. EcoRI linkers (12 bp CCGGAATT-CCGG) were added to BalI site (1487) (Martin-Zanca et al., 1989) and EcoRI sites in pUC118 were converted to HindII sites. The EcoRI/HindIII fragment containing the Trk kinase domain was fused to the XbaI/EcoRI fragment described above. The resulting BCR ± FLT (XbaI/XbaI fragment) and BCR ± TRK (XbaI/HindIII) sequences were cloned into pSRaMSVtkneo vector whose EcoRI site was converted to XbaI . The KpnI/BamHI fragment containing the entire P160v-ABL-coding sequence in pAcC12/v-ABL was cloned into KpnI/BamHI sites in pUC18. Then the v-ABL sequence was cut out as an EcoRI/HindIII fragment and was cloned into EcoRI/HindIII sites in pSRaMSVtkneo .
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